These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38866729)

  • 1. Fighting antibacterial drug resistance.
    Supuran CT
    Expert Opin Ther Pat; 2024 Jun; 34(6):397-400. PubMed ID: 38866729
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of
    Pisano L; Giovannuzzi S; Supuran CT
    Expert Opin Ther Pat; 2024 Jun; 34(6):511-524. PubMed ID: 38856987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbonic anhydrase and bacterial metabolism: a chance for antibacterial drug discovery.
    Capasso C; Supuran CT
    Expert Opin Ther Pat; 2024 Jun; 34(6):465-474. PubMed ID: 38506448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting bacterial topoisomerases: how to counter mechanisms of resistance.
    Tse-Dinh YC
    Future Med Chem; 2016 Jun; 8(10):1085-100. PubMed ID: 27285067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Challenges in the development of next-generation antibiotics: opportunities of small molecules mimicking mode of action of host-defense peptides.
    Wang M; Odom T; Cai J
    Expert Opin Ther Pat; 2020 May; 30(5):303-305. PubMed ID: 32149532
    [No Abstract]   [Full Text] [Related]  

  • 6. Fighting the enemy within.
    Tacconelli E; Autenrieth IB; Peschel A
    Science; 2017 Feb; 355(6326):689-690. PubMed ID: 28209857
    [No Abstract]   [Full Text] [Related]  

  • 7. Mechanism of quinolone action and resistance.
    Aldred KJ; Kerns RJ; Osheroff N
    Biochemistry; 2014 Mar; 53(10):1565-74. PubMed ID: 24576155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Current Case of Quinolones: Synthetic Approaches and Antibacterial Activity.
    Naeem A; Badshah SL; Muska M; Ahmad N; Khan K
    Molecules; 2016 Mar; 21(4):268. PubMed ID: 27043501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, green one-pot synthesis and molecular docking study of novel N,N-bis(cyanoacetyl)hydrazines and bis-coumarins as effective inhibitors of DNA gyrase and topoisomerase IV.
    Metwally NH; Abdallah SO; Mohsen MMA
    Bioorg Chem; 2020 Apr; 97():103672. PubMed ID: 32145481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotics versus resistant bacteria: recent patents. Foreword.
    Heinink A
    Expert Opin Ther Pat; 2010 Oct; 20(10):i. PubMed ID: 20839926
    [No Abstract]   [Full Text] [Related]  

  • 11. Research and development of antibiotics: insights from patents and citation network.
    Zhang M; Kong X; Zheng J; Wan JB; Wang Y; Hu Y; Shao R
    Expert Opin Ther Pat; 2016 May; 26(5):617-27. PubMed ID: 26986226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibacterial carbonic anhydrase inhibitors: an update on the recent literature.
    Supuran CT; Capasso C
    Expert Opin Ther Pat; 2020 Dec; 30(12):963-982. PubMed ID: 32806966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ATP-competitive DNA gyrase and topoisomerase IV inhibitors as antibacterial agents.
    Durcik M; Tomašič T; Zidar N; Zega A; Kikelj D; Mašič LP; Ilaš J
    Expert Opin Ther Pat; 2019 Mar; 29(3):171-180. PubMed ID: 30686070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibacterial resistance to antibiotics.
    Noah N
    Epidemiol Infect; 2024 May; 152():e72. PubMed ID: 38712589
    [No Abstract]   [Full Text] [Related]  

  • 15. What is inadequate antibacterial therapy?
    Moellering RC
    Clin Infect Dis; 2009 Oct; 49(7):1006-8. PubMed ID: 19719418
    [No Abstract]   [Full Text] [Related]  

  • 16. Novel heterodimer antibiotics: a review of recent patent literature.
    Long DD; Marquess DG
    Future Med Chem; 2009 Sep; 1(6):1037-50. PubMed ID: 21425993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Neisseria gonorrhoeae Type II Topoisomerases by the Novel Spiropyrimidinetrione AZD0914.
    Kern G; Palmer T; Ehmann DE; Shapiro AB; Andrews B; Basarab GS; Doig P; Fan J; Gao N; Mills SD; Mueller J; Sriram S; Thresher J; Walkup GK
    J Biol Chem; 2015 Aug; 290(34):20984-20994. PubMed ID: 26149691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting virulence not viability in the search for future antibacterials.
    Heras B; Scanlon MJ; Martin JL
    Br J Clin Pharmacol; 2015 Feb; 79(2):208-15. PubMed ID: 24552512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antibacterial drugs market.
    Kresse H; Belsey MJ; Rovini H
    Nat Rev Drug Discov; 2007 Jan; 6(1):19-20. PubMed ID: 17269159
    [No Abstract]   [Full Text] [Related]  

  • 20. Antibacterial resistance: an emerging 'zoonosis'?
    Labro MT; Bryskier JM
    Expert Rev Anti Infect Ther; 2014 Dec; 12(12):1441-61. PubMed ID: 25348154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.